Glenmark Pharmaceuticals Recalls Carvedilol Tablets Due to Impurity Hazard
Glenmark Pharmaceuticals recalled 14,976 bottles of Carvedilol Tablets on August 6, 2025. The recall follows findings of N-Nitroso Carvedilol Impurity-1 above FDA limits. Consumers should stop using the product immediately and contact their healthcare provider.